[1] |
李振华, 周建国, 刘志明, 等. 肺功能障碍患者围术期麻醉管理进展. 临床麻醉学杂志, 2022, 38(6):578-582.
|
[2] |
Howard SN, Oliver J, Sinclair R, et al.Functional classification and perioperative risk in chronic lung disease patients undergoing general anesthesia. Anesthesia Analgesia, 2021, 133(5):1291-1299.
|
[3] |
张骁, 李慧芳, 邹鹏飞. 不同类型肺功能障碍对术中通气策略的影响研究进展. 医学综述, 2023, 29(2):342-346.
|
[4] |
Abrahams M, Royse CF, Cooke R, et al.The role of DLCO and 6MWT in preoperative pulmonary risk assessment: evidence and applications. J Cardiothorac Vasc Anesth, 2020, 34(8):2015-2022.
|
[5] |
刘晓丹, 陈伟, 胡新宇. 肺康复在围术期麻醉中的应用价值. 中国临床医学, 2022, 29(5):645-648.
|
[6] |
Wang J, Zhao F, Li M, et al.Effects of preoperative pulmonary rehabilitation on postoperative complications in patients with impaired lung function: a meta-analysis. BMC Pulm Med, 2022, 22(1):109.
|
[7] |
吴倩倩, 姚敏, 杜启华. 微量营养素干预对肺功能障碍术前准备的促进作用. 中华麻醉学杂志, 2021, 41(12):1320-1324.
|
[8] |
He Y J, Sun LY, Lin F, et al.Induction agents and respiratory safety in compromised pulmonary patients: clinical considerations and recommendations. International Journal of Anesthesiology, 2021, 43(3):217-222.
|
[9] |
林浩宇, 胡珂, 孙展文. 吸入麻醉剂在肺功能受损患者中的应用研究进展. 临床麻醉学杂志, 2023, 39(1):44-48.
|
[10] |
Kim SH, Chen L, Williams G, et al.Monitoring and reversal of neuromuscular blockade in patients with impaired respiratory function. Current Anesthesiology Reports, 2022, 12(4):305-313.
|
[11] |
杨静怡, 黄海平, 徐文彬. 肺保护性通气策略在术中管理中的应用与优化. 医学研究杂志, 2023, 52(7):905-908.
|
[12] |
Zhao L, Mei Y, Thomas R, et al.Multimodal analgesia for thoracic surgery patients with reduced lung function: efficacy and safety evaluation. Eur J Anaesthesiol, 2021, 38(9):951-958.
|
[13] |
高梓涵, 胡建伟. 高流量鼻导管与无创通气在肺功能受限患者术后拔管管理中的比较. 中国现代医学杂志, 2022, 32(15):42-46.
|